Skip to main content
Top
Published in: Indian Journal of Surgery 1/2023

21-03-2022 | Peripheral Arterial Disease | Original Article

The Role of Serum Apelin Levels in Peripheral Artery Disease

Authors: Gündüz Yümün, Selami Gürkan, Ahsen Yilmaz, Savaş Güzel

Published in: Indian Journal of Surgery | Special Issue 1/2023

Login to get access

Abstract

Apelin is a bioactive mediator released by adipose tissue that can be involved in energy metabolism events and coronary artery disease. This study aims to investigate the role of serum apelin levels in patients with peripheral artery disease (PAD). The present observational case–control study consisted of 100 subjects (50 angiographically proven PAD patients and 50 healthy controls). Serum apelin and apelin receptor (APJ) levels were measured with blood samples. Clinical and laboratory findings were obtained from the hospital database system. The association between serum apelin levels, and PAD was investigated. The number of smokers and subjects with hypertension, coronary artery disease and diabetes mellitus was higher in the PAD group than in the control group (P < 0.05). Mean serum apelin levels were lower in the peripheral artery group than in the control group (mean: 13.94, SD 4.34 vs. mean: 16.79, SD 4.2, P = 0.001). On the other hand, the mean APJ levels were higher in the control group (mean: 36.1, SD 19.1 vs. mean: 27.7, SD 13.1, P = 0.019). There was no statistically significant difference between the two groups (20 (41.6%) vs. 21 (42%), P = 973) regarding the obesity. Our findings revealed that hypertension, smoking and diabetes mellitus rates were higher among patients with PAD. In fact, the lower apelin levels and higher APJ levels were risk factors associated with PAD; the obesity was not related with development of PAD.
Literature
1.
go back to reference Fowkes FG, Rudan D, Rudan I et al (2013) Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382:1329–1340CrossRefPubMed Fowkes FG, Rudan D, Rudan I et al (2013) Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382:1329–1340CrossRefPubMed
3.
go back to reference American Diabetes Association (2003) Peripheral arterial disease in people with diabetes. Diabetes Care 26:3333–3341CrossRef American Diabetes Association (2003) Peripheral arterial disease in people with diabetes. Diabetes Care 26:3333–3341CrossRef
4.
go back to reference Alzahrani HA, Wang D, Bakhotmah BA, Hu FB (2014) Risk factors for peripheral artery disease among patients with diabetes in Saudi Arabia. Vasc Med 19(2):103–111CrossRefPubMed Alzahrani HA, Wang D, Bakhotmah BA, Hu FB (2014) Risk factors for peripheral artery disease among patients with diabetes in Saudi Arabia. Vasc Med 19(2):103–111CrossRefPubMed
5.
go back to reference Japp AG, Cruden NL, Barnes G, van Gemeren N, Mathews J, Adamson J et al (2010) Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure. Circulation 121:1818–1827CrossRefPubMed Japp AG, Cruden NL, Barnes G, van Gemeren N, Mathews J, Adamson J et al (2010) Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure. Circulation 121:1818–1827CrossRefPubMed
6.
go back to reference Maguire JJ, Kleinz MJ, Pitkin SL, Davenport AP (2009) [Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease. Hypertension 54:98–604CrossRef Maguire JJ, Kleinz MJ, Pitkin SL, Davenport AP (2009) [Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease. Hypertension 54:98–604CrossRef
7.
go back to reference Falcao-Pires I, Leite-Moreira AF (2005) Apelin: a novel neurohumoral modulator of the cardiovascular system: pathophysiologic importance and potential use as a therapeutic target. Rev Port Cardiol 24(10):1263–1276PubMed Falcao-Pires I, Leite-Moreira AF (2005) Apelin: a novel neurohumoral modulator of the cardiovascular system: pathophysiologic importance and potential use as a therapeutic target. Rev Port Cardiol 24(10):1263–1276PubMed
8.
go back to reference Szokodi I, Tavi P, Foldes G, Voutilainen-Myllyla S, Ilves M, Tokola H et al (2002) Apelin, the novel endogenous ligand of the orphan receptor APJ. regulates cardiac contractility. Circ Res 91(5):434–440CrossRefPubMed Szokodi I, Tavi P, Foldes G, Voutilainen-Myllyla S, Ilves M, Tokola H et al (2002) Apelin, the novel endogenous ligand of the orphan receptor APJ. regulates cardiac contractility. Circ Res 91(5):434–440CrossRefPubMed
9.
go back to reference Kadoglou NP, Lampropoulos S, Kapelouzou A, Gkontopoulos A, Theofilogiannakos EK, Fotiadis G, Kottas G (2010) Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease–KOZANI STUDY. Transl Res 155(5):238–246CrossRefPubMed Kadoglou NP, Lampropoulos S, Kapelouzou A, Gkontopoulos A, Theofilogiannakos EK, Fotiadis G, Kottas G (2010) Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease–KOZANI STUDY. Transl Res 155(5):238–246CrossRefPubMed
10.
go back to reference (2017) 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases. Developed in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J 39(9):763–816 (2017) 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases. Developed in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J 39(9):763–816
11.
12.
go back to reference Bauersachs R, Zeymer U, Brière JB, Marre C, Bowrin K, Huelsebeck M (2019) Burden of coronary artery disease and peripheral artery disease: a literature review. Cardiovasc Ther 2019;26:8295054 Bauersachs R, Zeymer U, Brière JB, Marre C, Bowrin K, Huelsebeck M (2019) Burden of coronary artery disease and peripheral artery disease: a literature review. Cardiovasc Ther 2019;26:8295054
13.
go back to reference Aguilar-Salinas CA, García EG, Robles L, Riaño D, Ruiz-Gomez DG, García-Ulloa AC et al (2008) High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 93(10):4075–4079CrossRefPubMed Aguilar-Salinas CA, García EG, Robles L, Riaño D, Ruiz-Gomez DG, García-Ulloa AC et al (2008) High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 93(10):4075–4079CrossRefPubMed
14.
go back to reference Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH (2009) The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 25(9):88CrossRef Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH (2009) The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 25(9):88CrossRef
15.
go back to reference Bełtowski J (2006) Apelin and visfatin: unique “beneficial” adipokines upregulated in obesity? Med Sci Monit 12(6):RA12-119 Bełtowski J (2006) Apelin and visfatin: unique “beneficial” adipokines upregulated in obesity? Med Sci Monit 12(6):RA12-119
16.
go back to reference Yue P, Jin H, Xu S, Aillaud M, Deng AC, Azuma J et al (2011) Apelin decreases lipolysis via Gq. Gi. and AMPK-dependent mechanisms. Endocrinology 152:59–68CrossRefPubMed Yue P, Jin H, Xu S, Aillaud M, Deng AC, Azuma J et al (2011) Apelin decreases lipolysis via Gq. Gi. and AMPK-dependent mechanisms. Endocrinology 152:59–68CrossRefPubMed
17.
go back to reference Than A, Zhang X, Leow MK, Poh CL, Chong SK, Chen P (2014) Apelin attenuates oxidative stress in human adipocytes. J Biol Chem 289(6):3763–3774CrossRefPubMed Than A, Zhang X, Leow MK, Poh CL, Chong SK, Chen P (2014) Apelin attenuates oxidative stress in human adipocytes. J Biol Chem 289(6):3763–3774CrossRefPubMed
18.
go back to reference Lv S, Feng Y, Jiang Q, Lv X, Yang Y (2021) Relationship between Apelin/APJ signaling, oxidative stress, and diseases. Oxidative Med Cell Longev 2021:1–7 Lv S, Feng Y, Jiang Q, Lv X, Yang Y (2021) Relationship between Apelin/APJ signaling, oxidative stress, and diseases. Oxidative Med Cell Longev 2021:1–7
19.
go back to reference Akcilar R, Yumun G, Bayat Z, Donbaloglu O, Erselcan K, Ece E, Kokdasgil H, Genc O (2015) Characterization of the apelin -1860T>C polymorphism in Turkish coronary artery disease patients and healthy individuals. Int J Physiol Pathophysiol Pharmacol 7(4):165–171PubMedPubMedCentral Akcilar R, Yumun G, Bayat Z, Donbaloglu O, Erselcan K, Ece E, Kokdasgil H, Genc O (2015) Characterization of the apelin -1860T>C polymorphism in Turkish coronary artery disease patients and healthy individuals. Int J Physiol Pathophysiol Pharmacol 7(4):165–171PubMedPubMedCentral
20.
21.
go back to reference Chen T, Wu B, Lin R (2017) Association of apelin and apelin receptor with the risk of coronary artery disease: a meta-analysis of observational studies. Oncotarget 8(34):57345–57355CrossRefPubMedPubMedCentral Chen T, Wu B, Lin R (2017) Association of apelin and apelin receptor with the risk of coronary artery disease: a meta-analysis of observational studies. Oncotarget 8(34):57345–57355CrossRefPubMedPubMedCentral
22.
go back to reference Lee DK, Saldivia VR, Nguyen T, Cheng R, George SR, O’Dowd BF (2005) Modification of the terminal residue ofapelin-13 antagonizes its hypotensive action. Endocrinology. 146(1):231–236CrossRefPubMed Lee DK, Saldivia VR, Nguyen T, Cheng R, George SR, O’Dowd BF (2005) Modification of the terminal residue ofapelin-13 antagonizes its hypotensive action. Endocrinology. 146(1):231–236CrossRefPubMed
23.
go back to reference Kaplan M, Yavuz F, Kaplan GI, Bursa N, Vuruşkan E, Sucu M (2021) Elabela as a novel marker: well-correlated with WIfI amputation risk score in lower extremity arterial disease patients. Anatol J Cardiol 25(5):330–337PubMedPubMedCentral Kaplan M, Yavuz F, Kaplan GI, Bursa N, Vuruşkan E, Sucu M (2021) Elabela as a novel marker: well-correlated with WIfI amputation risk score in lower extremity arterial disease patients. Anatol J Cardiol 25(5):330–337PubMedPubMedCentral
24.
go back to reference Butruille L, Drougard A, Knauf A, Moitrot E, Valet P, Storme L, Deruelle P, Lesage J (2013) The apelinergic system: sexual dimorphism and tissue-specific modulations by obesity and insulin resistance in female mice. Peptides 46(1):94–101CrossRefPubMed Butruille L, Drougard A, Knauf A, Moitrot E, Valet P, Storme L, Deruelle P, Lesage J (2013) The apelinergic system: sexual dimorphism and tissue-specific modulations by obesity and insulin resistance in female mice. Peptides 46(1):94–101CrossRefPubMed
Metadata
Title
The Role of Serum Apelin Levels in Peripheral Artery Disease
Authors
Gündüz Yümün
Selami Gürkan
Ahsen Yilmaz
Savaş Güzel
Publication date
21-03-2022
Publisher
Springer India
Published in
Indian Journal of Surgery / Issue Special Issue 1/2023
Print ISSN: 0972-2068
Electronic ISSN: 0973-9793
DOI
https://doi.org/10.1007/s12262-022-03370-y

Other articles of this Special Issue 1/2023

Indian Journal of Surgery 1/2023 Go to the issue
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare